Cancer Immunology Research | American Association for Cancer Research

Skip to Main Content

Advertisement

Close

AACR Journals
For Authors
About Us
Article Collections
Alerts
News
Cancer Hallmarks
Webinars

header search

search input Search input auto suggest

Search

Advanced Search

Menu

About
Articles
For Authors
Alerts
News
Cancer Hallmarks
Webinars
10th Anniversary

Skip Nav Destination

Current Issue

Volume 12,

Issue 12

1 December 2024

View This Issue

About the Journal

Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials. Read More About the Journal

Editors-in-Chief

Robert D. Schreiber
Philip D. Greenberg

View Full Editorial Board

Impact Factor

8.1

SUBMIT TO JOURNAL

Featured Articles

Research Article

Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment

Zahraa Rahal, et al.

Research Article

Peripheral Blood–Derived PD-1/CD28–CD19 CAR–Modified PD-1⁺ T-Cell Therapy in Patients with Solid Tumors

Zhen Zhang, et al.

Research Article

Spatially Resolved Whole-Transcriptomic and Proteomic Profiling of Lung Cancer and Its Immune Microenvironment According to PD-L1 Expression

Jaemoon Koh, et al.

Trending - Altmetric

The article titled, Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens, has an Alt Metric Attention Score of 34.6. Click to see more of this article's metrics.

Read the article titled, Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens

Last mentioned on Tuesday December 10 2024

The article titled, Natural killer cell–mediated cytotoxicity shapes the clonal evolution of B cell leukaemia, has an Alt Metric Attention Score of 2.35. Click to see more of this article's metrics.

Read the article titled, Natural killer cell–mediated cytotoxicity shapes the clonal evolution of B cell leukaemia

Last mentioned on Saturday December 7 2024

The article titled, Tertiary lymphoid structures in pancreatic cancer are structurally homologous, share gene expression patterns and B-cell clones with secondary lymphoid organs but show increased T-cell activation, has an Alt Metric Attention Score of 1. Click to see more of this article's metrics.

Read the article titled, Tertiary lymphoid structures in pancreatic cancer are structurally homologous, share gene expression patterns and B-cell clones with secondary lymphoid organs but show increased T-cell activation

Last mentioned on Thursday December 12 2024

The article titled, Identification and phenotypic characterization of neoantigen-specific cytotoxic CD4+ T cells in endometrial cancer, has an Alt Metric Attention Score of 1. Click to see more of this article's metrics.

Read the article titled, Identification and phenotypic characterization of neoantigen-specific cytotoxic CD4+ T cells in endometrial cancer

Last mentioned on Tuesday December 10 2024

The article titled, BHLHE40 Regulates the T-Cell Effector Function Required for Tumor Microenvironment Remodeling and Immune Checkpoint Therapy EfficacyEffective Immune Checkpoint Therapy Requires BHLHE40, has an Alt Metric Attention Score of 39.45. Click to see more of this article's metrics.

Read the article titled, BHLHE40 Regulates the T-Cell Effector Function Required for Tumor Microenvironment Remodeling and Immune Checkpoint Therapy EfficacyEffective Immune Checkpoint Therapy Requires BHLHE40

Last mentioned on Tuesday December 10 2024

Latest
Most Read
Most Cited

CD27-Armored BCMA CAR T-cell Therapy (CBG-002) for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial

The FcγRIIIA (CD16) L48-H/R polymorphism enhances NK cell-mediated antibody-dependent cellular cytotoxicity by promoting serial killing

The C5a/C5aR1 axis promotes migration of tolerogenic dendritic cells to lymph nodes, impairing the anticancer immune response

Mathematical modeling predicts optimal immune checkpoint inhibitor and radiotherapy combinations and timing of administration

Issues
Online First
News

Twitter/X

Online ISSN 2326-6074
Print ISSN 2326-6066

AACR Journals

Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics

Information on Advertising & Reprints
Information for Institutions/Librarians
RSS Feeds
Privacy Policy

Twitter
LinkedIn
Facebook
Youtube

Copyright © 2023 by the American Association for Cancer Research.

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.

Accept